Abiopharma

Baird Global Healthcare Conference

Wells Fargo Healthcare Conference

New Form 144 - Cadrenal Therapeutics, Inc. Filed: 2025-08-27 AccNo: 0002007317-25-000971 Size: 4 KB

New Form SCHEDULE 13G/A - OmniAb, Inc. Filed: 2025-08-27 AccNo: 0001011438-25-000456 Size: 24 KB

Reimagine leadership and culture at HUB25

New Form 6-K - MESOBLAST LTD Filed: 2025-08-27 AccNo: 0001345099-25-000060 Size: 386 KB

New Form 6-K - ImmunoPrecise Antibodies Ltd. Filed: 2025-08-27 AccNo: 0000950170-25-111598 Size: 49 KB

New Form 144 - VERTEX PHARMACEUTICALS INC / MA Filed: 2025-08-27 AccNo: 0001959173-25-005557 Size: 4 KB

New Form 144 - HOOKIPA Pharma Inc. Filed: 2025-08-27 AccNo: 0001970051-25-000025 Size: 4 KB

Hawkins, Inc. to Participate in Sidoti & Company’sSmall Cap Virtual Investor Conference

New Form SCHEDULE 13G - Longeveron Inc. Filed: 2025-08-27 AccNo: 0001641172-25-025643 Size: 6 KB

New Form SCHEDULE 13G - Celularity Inc Filed: 2025-08-27 AccNo: 0001641172-25-025647 Size: 6 KB

New Form SCHEDULE 13G - Calidi Biotherapeutics, Inc. Filed: 2025-08-27 AccNo: 0001641172-25-025645 Size: 6 KB

New Form 3 - Calidi Biotherapeutics, Inc. Filed: 2025-08-27 AccNo: 0001641172-25-025641 Size: 3 KB

New Form 8-K - Penumbra Inc Filed: 2025-08-27 AccNo: 0001321732-25-000101 Size: 318 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits